Skip to main content
We are currently unable to accept payments via our website. Please contact us on 1300 306 622 for assistance.
About the APA
Acupuncture & dry needling
Cancer, palliative care and lymphoedema
Women's, Men's and Pelvic Health
Leadership & management
Why join the APA
Category eligibilty & fees
Manage your membership
Member only access
Courses and events
Conference & tours
APA Conference 2018
Sports physiotherapy Hong Kong
2018 International Master Class
Professional development guide
Organise your event
Employment at the APA
Australian College of Physiotherapists
Working in Australia
Safer communities for children
Guidelines for writing clinical notes
Frequently asked questions
Social media guide
Private practice support
Business group resources
HR in practice
National physiotherapy service descriptors
Partners & endorsed products
Scope of practice
Research & Publications
Publications and Advertising
Journal of Physiotherapy
Physiotherapy Research Foundation
APA research portal
Physio & you
What is physio?
Find a physio
New research highlighted at awards night
New research findings based on a randomised clinical trial of more than 200 patients with gluteal tendinopathy will get its first live Australian physiotherapy airing during a presentation at the APA’s New South Wales Branch Awards night in August.
APA Sports Physiotherapist and professor in sports physiotherapy at the University of Queensland, Bill Vicenzino, will discuss the findings of the trial during his keynote presentation at the awards night, to be held in Ultimo on Friday 3 August from 6.30pm. He will also present the tennis elbow clinical trial that was rated in the top 15 (of 29,000) PEDro-indexed ground-breaking trials that mark important milestones in the evolution of physiotherapy treatment.
The ‘Clinical implications and applications of the research of two common insertional tendinopathies: gluteal and lateral elbow’ presentation will detail the clinical trials, which compared physiotherapy-delivered manual therapy, education and exercise programs with a steroid injection and ‘wait and see’ program—the findings of which Bill says are new, exciting and ‘hot off the press for the gluteal tendinopathy study’.
‘Basically I like to feel confident that there is evidence supporting a management approach; for tennis elbow there’s a number of studies that show quite a predictable pattern of response for commonly-used injections and physiotherapy,’ Bill says. ‘So I’d like to be able to tell the awards night attendees about that, and show them how the evidence links to clinical practice. The information I’ll be sharing about gluteal tendinopathy has not been seen before. It’s quite exciting, it’s quite a pragmatic physio program that delivers nice outcomes. So there will be some evidence-based takeaways which can be applied in clinics the next day.’
Bill says he was fortunate to get NHMRC funding for the clinical trial and he expects the paper will soon be published in The BMJ as an open access freely available paper. He also plans to help disseminate the results through online platforms, in his teaching, and through presentations.
‘I think something about these physiotherapy treatment programs that clinicians like is that they take a pragmatic approach to education and exercise, with a real alignment to the thinking of the majority of contemporary physiotherapists,’ Bill says. ‘So there’s some really simple advice that is carried through to the exercise progressions. Once physios have a look at this, some of them will be tempted to say “well I already do that”, so hopefully it won’t be that difficult in the translation of the findings of the clinical trials. Stopping clinicians from injecting these patients appears to be a bit harder because in tennis elbow we’ve shown that cortisone injections are not good, in fact they’re very bad. Yet 12 years after our initial tennis elbow study the rate of patients receiving injections has not abated.’
Bill, who won an award for the best conference presentation at the Scandinavian Sports Medicine Congress for the gluteal tendinopathy clinical trial, says he considers it an honour to be asked to present at the New South Wales Branch Awards and dinner, as it is a chance for him to contribute to the profession he is passionate about and that has afforded him a living. He will hold the floor for 45 to 60 minutes during his presentation and will follow with a question and answer session, giving physiotherapists an opportunity to learn more about the research and how it can translate into clinical practice.
‘I’m looking forward to the evening. I find with these events everyone’s nice and relaxed, generally there is some good discussion and the awards are always exciting.’
Orkambi® PBS listing provides quality of life to CF patients
The Australian Physiotherapy Association (APA) welcomes the announcement this week by federal Health Minister Greg Hunt that the cystic fibrosis (CF) drug Orkambi® will be added to the PBS effective October 1 2018. Access is available to families imm
September | Committed to building brand physio
I've recently been reflecting on the rising prominence of 'brand physio'. It is only a little over a year since we launched our national consumer campaign, on what...
Advocacy agenda is set
Having sought commitments from the incoming Liberal government prior to the election, the South Australian advocacy agenda has been set.
Paddling towards good health
In July, a team of 21 breast cancer survivors from Hobart travelled to Florence Italy for the International Breast Cancer Participatory Dragon Boat Championships.